This finding could be interpreted in light of a previous study involving pheochromocytoma patients reporting that ADRA2A SNPs rs553668/rs521674 were associated with higher dosage requirements of α-adrenergic receptor blockers to control blood pressure (Berends et al., 2022). Here, ADRA2A is linked to hereditary pheochromocytoma-paraganglioma.